Covered recipient · General Payments record
OKECHUKWU OKOYE
General Payments · PY2021–2024
$534.26
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $417.90 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $103.53 | 4 |
| Amgen Inc. | $101.35 | 4 |
| ABBVIE INC. | $79.32 | 4 |
| UCB, Inc. | $53.17 | 2 |
| Radius Health, Inc. | $33.29 | 1 |
| GlaxoSmithKline, LLC. | $28.24 | 1 |
| ANI Pharmaceuticals, Inc. | $19.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2021
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.35 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105149964 | CMS |
| ABBVIE INC. | $17.98 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105149966 | CMS |
| ABBVIE INC. | $18.30 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105149968 | CMS |
| ABBVIE INC. | $15.69 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105149970 | CMS |
| Amgen Inc. | $22.18 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117644757 | CMS |
| Amgen Inc. | $28.85 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115979982 | CMS |
| Amgen Inc. | $26.33 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115979988 | CMS |
| Amgen Inc. | $23.99 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115979993 | CMS |
| ANI Pharmaceuticals, Inc. | $19.00 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091159026 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.75 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110514440 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.94 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110508066 | CMS |
| AstraZeneca Pharmaceuticals LP | $32.22 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110508832 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.62 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110510000 | CMS |
| GlaxoSmithKline, LLC. | $28.24 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116497601 | CMS |
| Radius Health, Inc. | $33.29 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089980954 | CMS |
| UCB, Inc. | $26.59 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143122896 | CMS |
| UCB, Inc. | $26.58 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143122898 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.